Gayathri Anandappa, MBBS, MRCP, MPhil, The Royal Marsden NHS Foundation Trust, London, UK, discusses highlights from the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, touching on progress in patients with rare cancers such as cholangiocarcinoma and hepatocellular carcinoma, as well as the importance of developing novel approaches for patients with pancreatic cancers. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
